Habib Joseph Dable

Habib Dable is the former President & CEO of Acceleron Pharma and brings nearly three decades of experience working with emerging biotech and big pharma companies. Prior to joining Acceleron in 2016, Habib worked at Bayer AG where over the course of his 22-year tenure, he served in roles of increasing responsibility, including as Global Head, Neurology and Ophthalmology, ultimately becoming President of U.S. Pharmaceuticals. During his time at Bayer AG, Habib led the launch of various blockbuster brands, including EYLEA®, Stivarga®, and Xofigo®. Habib is also a former Independent Director of Millendo Therapeutics and previously served on the Board of Directors of the Biotechnology Innovation Organization (BIO). He currently serves as an Independent Director at Blueprint Medicines and Albireo Pharma and is a part-time Venture Partner at RA Capital Management. Habib received a bachelor’s degree in Business Administration and his MBA from the University of New Brunswick.